Internal Medicine, Infectious Disease · Asheville, NC
NPI
1194775098
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
53 S French Broad Ave, Ste 200
Asheville, NC, 28801
Phone (828) 258-9635
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
393 services
Medicare patients, 2024
193
Average age 71
Drug cost, 2024
$982K
496 prescriptions
Company payments, 2025
$179
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bruce F Israel was code 99233 (hospital e&m - subsequent), 149 times for 83 patients. In total Bruce F Israel billed 393 services in 18 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 149 | 83 | $91.38 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 87 | 63 | $59.06 | $5,138 |
| 99223 Hospital E&M - Initial | Facility | 41 | 41 | $133.29 | $5,465 |
| 99213 Office E&M - Established | Office | 37 | 27 | $66.66 | $2,466 |
| 99214 Office E&M - Established | Office | 23 | 16 | $82.49 | $1,897 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $100.96 | $1,211 |
By year: 2022 $38K for 483 services; 2023 $33K for 370 services; 2024 $34K for 393 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bruce F Israel prescribed most often to Medicare patients was Triumeq (Abacavir/Dolutegravir/Lamivudi), with 90 prescriptions and refills. In total Bruce F Israel wrote 496 Medicare prescriptions that cost $982K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triumeq Abacavir/Dolutegravir/Lamivudi | 90 | 90 | Under 11 | $357K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 71 | 77 | Under 11 | $316K |
| Atazanavir Sulfate Generic | 29 | 29 | Under 11 | $9,201 |
| Cefadroxil Generic | 25 | 31 | Under 11 | $1,730 |
| Descovy Emtricitabine/Tenofov Alafenam | 24 | 24 | Under 11 | $51K |
| Amoxicillin Generic | 23 | 23 | Under 11 | $418 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 20 | 20 | Under 11 | $345 |
| Sodium Chloride 0.9 % Sodium Chloride | 18 | 18 | Under 11 | $375 |
| Doxycycline Hyclate Generic | 17 | 21 | Under 11 | $513 |
| Abacavir Abacavir Sulfate | 15 | 15 | Under 11 | $5,733 |
| Tivicay Dolutegravir Sodium | 13 | 13 | Under 11 | $39K |
| Lamivudine-Zidovudine Lamivudine/Zidovudine | 12 | 12 | Under 11 | $6,958 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 12 | 12 | Under 11 | $56K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 12 | 12 | Under 11 | $46K |
| Cefazolin Sodium Generic | 11 | 11 | Under 11 | $980 |
Brand drugs: 255 claims; generic drugs: 241 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bruce F Israel $179 ($179 in general payments such as food, travel and fees) from 2 companies. The largest payer was Phathom Pharmaceuticals, Inc. with $110.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.